Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Gold Processing Underway. CY25 Gold Production Commences March 10, 2025 WOA Secures New Sales in Europe, Latin America & Australia March 10, 2025 BHP to Spend up to A$40M to Explore for Tier 1 Copper-Silver Deposits on CBE Tenements in Botswana March 10, 2025
BHP to Spend up to A$40M to Explore for Tier 1 Copper-Silver Deposits on CBE Tenements in Botswana March 10, 2025